Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective lidocaine volume for double-injection costoclavicular brachial plexus block
ISRCTN16060312Phase 4Terminated
- Sponsor
- McGill University Health Centre
- Start
- Nov 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine and epinephrine in None, sponsored by McGill University Health Centre. Primary endpoints: Successful block / ED90 estimation, Composite sensorimotor block score and 2 more. Started Nov 2025; status: terminated.
02
Drugs
lidocaineepinephrine
Beyond the preview
Go deeper on ISRCTN16060312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16060312.